Generic Name: Nivolumab for Hodgkin's Lymphoma ()
Nivolumab for Hodgkin's Lymphoma Reviews
"I have both NHL and HL, have been on Opdivo since Feb 2017, I've had very little side effects, mostly a small rash. My Hemaglobin went from 59 to 145, I feel great, and I'm preparing for a donor stem cell transplant in Sept 2017 I've had an autologous stem cell transplant and several different chemos Terry Burlington, ontario"
More about nivolumab
- Check interactions
- Compare alternatives
- Reviews (126)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Patient resources
- Nivolumab drug information
Other brands
Opdivo
Professional resources
- Nivolumab monograph
Other brands
Opdivo
Related treatment guides
- Esophageal Carcinoma
- Head and Neck Cancer
- Colorectal Cancer
- Hepatocellular Carcinoma
